BMRN vs PTGX
BioMarin Pharmaceutical Inc. · Protagonist Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | BMRN | PTGX |
|---|---|---|
| Price | $60.26 | $141.86 |
| Market Cap | $11.66B | $9.18B |
| P/E | 33.43 | — |
| P/B | 1.85 | 10.91 |
| P/S | 3.62 | 199.49 |
| ROE | 5.5% | -15.5% |
| Net Margin | 10.8% | -282.8% |
| Gross Margin | — | — |
| Revenue Growth | 12.9% | -89.4% |
| Dividend Yield | — | — |
| EPS | $1.80 | -$2.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.